Clinical Trial Update: "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of JZP-110 for excessive sleepiness in obstructive sleep apnea has completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• JZP-110

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Obstructive Sleep Apnea | Phase 3 | Status: COMPLETED | Results posted: 2019-07-23